Skip to content

ADVERTISEMENT

Bragar Eagel & Squire, PC Is Investigating Porch,


ADVERTISEMENT

NEW YORK, May 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Porch Group, Inc. (NASDAQ: PRCH), UpHealth, Inc. (NYSE : UPH), Core Scientific, Inc. (NASDAQ: CORZ), and Roblox Corp. (NYSE: RBLX). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Porch Group, Inc. (NASDAQ: PRCH)

Porch Group is a vertical software platform for the home, providing software and services to home services companies.

On March 1, 2022, after the market closed, Porch Group disclosed that it could not timely file its 2021 annual report. The Company also disclosed that it had identified material weaknesses in its internal control over financial reporting.


ADVERTISEMENT

On this news, Porch Group’s stock declined by $0.87 per share, or approximately 12%, from $7.28 per share to close at $6.41 per share on March 2, 2022.

For more information on the Porch Group investigation go to: https://bespc.com/cases/PRCH

UpHealth, Inc. (NYSE:UPH)

UpHealth, formerly Gigcapital2, Inc., is a global digital health company that delivers technology, infrastructure and services to modernize care delivery and health management.

In a March 30, 2022 press release, UpHealth announced that “[o]n March 25, 2022, the Audit Committee of the Board of Directors of UpHealth, after considering the recommendations of management, concluded that the Company’s condensed consolidated financial statements included in the Company’s Quarterly Report on Form 10-Q for the three and nine month periods ended September 30, 2021 (the ‘Non-Reliance Periods’) as previously filed with the [SEC] should not be relied upon because of errors identified therein…” UpHealth also reported that “

.

SHARE THIS POST

ADVERTISEMENT

Leave a Reply

Your email address will not be published.


ADVERTISEMENT

ADVERTISEMENT